Reuters logo
BRIEF-Incyte says first patient treated in Phase 3 clinical trial of itacitinib
July 20, 2017 / 11:50 AM / 2 months ago

BRIEF-Incyte says first patient treated in Phase 3 clinical trial of itacitinib

July 20 (Reuters) - Incyte Corp

* Incyte announces first patient treated in Phase 3 clinical trial of itacitinib for acute graft-versus-host disease

* Incyte- Trial to evaluate efficacy, safety of itacitinib, in combination with corticosteroids versus placebo plus corticosteroids in patients with acute gvhd​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below